corkmeister
Established Member
- Reaction score
- 334
Let me start off by saying that I'm glad topical dutasteride is working for you Mustang. But I myself remain skeptical in terms of its systemic effects.
Dimitri, you're correct in the sense that most topical finasteride dosages tend to result in near-oral levels of DHT-inhibition (although the studies on this sometimes give mixed and confusing results).
Studies do show that even low dosages of oral finasteride (around 0.05mg and up) accumulate and eventually start significantly inhibiting DHT - despite its relatively short half life. Logically speaking, high enough topical dosages should also accumulate and result in the same effect, which is what several studies show and what many users experience. And at least one of the studies that doesn't show this checked DHT-levels after like 10 days, which is too short of a time frame to account for accumulation.
Finding the appropriate topical finasteride dose (that inhibits DHT in the scalp, but not systemically) has been somewhat of a holy grail in itself. I'm quite convinced that the dosage must be very low, or at least much lower than what most topical formulations tend to contain nowadays. With dosages like 0.25% (which is 2.5 mg of finasteride per dose) I can almost guarantee that enough of it will go systemic and start accumulating over time.
Mazzarella supposedly used an appropriate topical dose in a study from 1999 with 0.01% per day (or 0.005% twice-daily, to be more precise). He tested DHT-levels in the blood and found no inhibition after more than a year, but did note a significant improvement in terms of hair growth. However, several people have tried to replicate this in the past and ended up with systemic DHT-inhibition anyway.
Whatever the case may be. My point is that, considering the above, I don't see how this would be any different for dutasteride. It seems to me that finding the appropriate dose is even more difficult (albeit not impossible), in part due to its much longer half life and the lack of studies to go off of. It would take a lot of trial and error. Even when considering liposomal vehicles; I don't believe that liposomal formulations prevent all systemic absorption while delivering dutasteride to where it needs to be. If it penetrates the scalp, I can only assume that some of it will go systemic and starts accumulating over a longer period of time, resulting in systemic DHT-inhibition.
I'm open to counter-arguments, as I hope I'm mistaken and I'm not a professional in this field. But it seems too good to be true.
Dimitri, you're correct in the sense that most topical finasteride dosages tend to result in near-oral levels of DHT-inhibition (although the studies on this sometimes give mixed and confusing results).
Studies do show that even low dosages of oral finasteride (around 0.05mg and up) accumulate and eventually start significantly inhibiting DHT - despite its relatively short half life. Logically speaking, high enough topical dosages should also accumulate and result in the same effect, which is what several studies show and what many users experience. And at least one of the studies that doesn't show this checked DHT-levels after like 10 days, which is too short of a time frame to account for accumulation.
Finding the appropriate topical finasteride dose (that inhibits DHT in the scalp, but not systemically) has been somewhat of a holy grail in itself. I'm quite convinced that the dosage must be very low, or at least much lower than what most topical formulations tend to contain nowadays. With dosages like 0.25% (which is 2.5 mg of finasteride per dose) I can almost guarantee that enough of it will go systemic and start accumulating over time.
Mazzarella supposedly used an appropriate topical dose in a study from 1999 with 0.01% per day (or 0.005% twice-daily, to be more precise). He tested DHT-levels in the blood and found no inhibition after more than a year, but did note a significant improvement in terms of hair growth. However, several people have tried to replicate this in the past and ended up with systemic DHT-inhibition anyway.
Whatever the case may be. My point is that, considering the above, I don't see how this would be any different for dutasteride. It seems to me that finding the appropriate dose is even more difficult (albeit not impossible), in part due to its much longer half life and the lack of studies to go off of. It would take a lot of trial and error. Even when considering liposomal vehicles; I don't believe that liposomal formulations prevent all systemic absorption while delivering dutasteride to where it needs to be. If it penetrates the scalp, I can only assume that some of it will go systemic and starts accumulating over a longer period of time, resulting in systemic DHT-inhibition.
I'm open to counter-arguments, as I hope I'm mistaken and I'm not a professional in this field. But it seems too good to be true.
Last edited: